Histologic progression of acne inversa/hidradenitis suppurativa: Implications for future investigations and therapeutic intervention.

Autor: Dunstan RW; Abbvie Bioresearch Center, Worcester, MA, USA., Salte KM; AbbVie Inc, North Chicago, IL, USA., Todorović V; AbbVie Inc, North Chicago, IL, USA., Lowe M; Department of Dermatology, University of California, San Francisco, CA, USA., Wetter JB; AbbVie Inc, North Chicago, IL, USA., Harms PW; Department of Pathology, University of Michigan, Ann Arbor, MI, USA., Burney RE; Department of Surgery, University of Michigan, Ann Arbor, MI, USA., Scott VE; AbbVie Inc, North Chicago, IL, USA., Smith KM; Abbvie Cambridge Research Center, Cambridge, MA, USA., Rosenblum MD; Department of Dermatology, University of California, San Francisco, CA, USA., Gudjonsson JE; Department of Dermatology, University of Michigan, Ann Arbor, MI, USA., Honore P; AbbVie Inc, North Chicago, IL, USA.

Publikováno v: Experimental dermatology [Exp Dermatol] 2021 Jun; Vol. 30 (6), pp. 820-830. Date of Electronic Publication: 2021 Jan 20.

Targeting Anti-TGF- β Therapy to Fibrotic Kidneys with a Dual Specificity Antibody Approach.

Autor: McGaraughty S; AbbVie Discovery Lake County, North Chicago, Illinois; and steve.p.mcgaraughty@abbvie.com., Davis-Taber RA; AbbVie Bioresearch Center, Worcester, Massachusetts., Zhu CZ; AbbVie Discovery Lake County, North Chicago, Illinois; and., Cole TB; AbbVie Discovery Lake County, North Chicago, Illinois; and., Nikkel AL; AbbVie Discovery Lake County, North Chicago, Illinois; and., Chhaya M; AbbVie Bioresearch Center, Worcester, Massachusetts., Doyle KJ; AbbVie Discovery Lake County, North Chicago, Illinois; and., Olson LM; AbbVie Discovery Lake County, North Chicago, Illinois; and., Preston GM; AbbVie Bioresearch Center, Worcester, Massachusetts., Grinnell CM; AbbVie Bioresearch Center, Worcester, Massachusetts., Salte KM; AbbVie Discovery Lake County, North Chicago, Illinois; and., Giamis AM; AbbVie Discovery Lake County, North Chicago, Illinois; and., Luo Y; AbbVie Discovery Lake County, North Chicago, Illinois; and., Sun V; AbbVie Bioresearch Center, Worcester, Massachusetts., Goodearl AD; AbbVie Bioresearch Center, Worcester, Massachusetts., Gopalakrishnan M; AbbVie Discovery Lake County, North Chicago, Illinois; and., Lacy SE; AbbVie Bioresearch Center, Worcester, Massachusetts.

Publikováno v: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2017 Dec; Vol. 28 (12), pp. 3616-3626. Date of Electronic Publication: 2017 Aug 21.

A loss‐of‐function NCSTN mutation associated with familial Dowling Degos disease and hidradenitis suppurativa.

Autor: de Oliveira, Ana Sofia Lima Estevao¹ (AUTHOR), de Siqueira, Roberta Cardoso² (AUTHOR), Nait‐Meddour, Cécile³ (AUTHOR), Tricarico, Paola Maura⁴ (AUTHOR), Moura, Ronald⁴ (AUTHOR), Agrelli, Almerinda⁵ (AUTHOR), d'Adamo, Adamo Pio^4,6 (AUTHOR), Jamain, Stéphane³ (AUTHOR), Crovella, Sergio⁷ (AUTHOR), de Fátima Medeiros Brito, Maria² (AUTHOR), Boniotto, Michele³ (AUTHOR) michele.boniotto@inserm.fr, Brandão, Lucas André Cavalcanti^1,8 (AUTHOR)

Publikováno v: Experimental Dermatology. Nov2023, Vol. 32 Issue 11, p1935-1945. 11p.

Bone Metabolism in Patients with Hidradenitis Suppurativa: A Case-control Study.

Autor: NAVARRO, Iñigo¹, GONZÁLEZ-LÓPEZ, Marcos A.^1,2,3 marcosg@aedv.es, SIERRA, Isabel³, Manuel OLMOS, José^2,3,4, BLANCO, Ricardo^3,5, HERNÁNDEZ, José Luis^2,3,4

Publikováno v: Acta Dermato-Venereologica. 2022, Vol. 102, p1-6. 6p.

Considerations for defining and diagnosing generalized pustular psoriasis.

Autor: Prajapati VH; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.; Dermatology Research Institute, Calgary, Alberta, Canada.; Skin Health & Wellness Centre, Calgary, Alberta, Canada.; Probity Medical Research Inc., Calgary, Alberta, Canada., Lynde CW; Lynde Dermatology, Probity Medical Research, Markham and Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Gooderham MJ; SKiN Health, Probity Medical Research, Queen's University, Peterborough, Ontario, Canada., Hong HC; Division of Dermatology and Skin Science, University of British Columbia, Surrey, British Columbia, Canada.; Probity Medical Research Inc., Surrey, British Columba, Canada., Kirchhof MG; Division of Dermatology, Faculty of Medicine, University of Ottawa, and the Ottawa Hospital, Ottawa, Ontario, Canada., Lansang P; Division of Dermatology, Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada.; Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada.; The Hospital for Sick Children, Toronto, Ontario, Canada., Ringuet J; Centre de Recherche Dermatologique du Québec (CRDQ), Québec, Quebec, Canada., Turchin I; Brunswick Dermatology Center and Probity Medical Research, Fredericton, New Brunswick, Canada.; Department of Medicine, Dalhousie University, Halifax, Nova Scotia, Canada., Vender R; Division of Dermatology, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.; Dermatrials Research Inc., Hamilton, Ontario, Canada., Yeung J; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Probity Medical Research Inc., Toronto, Ontario, Canada., Papp KA; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Probity Medical Research Inc., Waterloo, Ontario, Canada.; Alliance Clinical Trials, Waterloo, Ontario, Canada.

Publikováno v: Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2024 Sep 06. Date of Electronic Publication: 2024 Sep 06.